APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Trial Profile

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2017

At a glance

  • Drugs Fenretinide (Primary)
  • Indications Cystic fibrosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms APPLAUD
  • Sponsors Laurent Pharmaceuticals
  • Most Recent Events

    • 25 Aug 2017 Status changed from planning to not yet recruiting.
    • 19 Apr 2017 According to a Laurent Pharmaceuticals media release, company plans to initiate this study later 2017.
    • 19 Apr 2017 According to a Laurent Pharmaceuticals media release, the company received the IND approval from the US FDA and the Clinical Trial Application ("CTA") with Health Canada.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top